ABSTRACT Background: The effect of assay drifts over time on serum 25-hydroxyvitamin D [25(OH)D] concentrations were not accounted for in previous national survey studies. Thus, previously reported associations between 25(OH)D with cardiometabolic risk factors using data from NHANES were likely over-or underestimated. Moreover, associations between serum 25(OH)D and metabolic syndrome (MetSyn), insulin resistance (IR), and inflammation are unclear in children.
. Health concerns associated with low vitamin D status are on the rise in children. Vitamin D is required not only for bone health (4) but also has been reported to play a role in a range of ailments such as autoimmune disease (5), cardiovascular disease (CVD) (6), type 2 diabetes (T2D) (7) , hypertension (8) , depression (9) , and certain types of cancer (10) .
Metabolic syndrome (MetSyn) is characterized by abdominal adiposity, dyslipidemia, and elevated glucose and blood pressure (BP). Although insulin resistance (IR) is not part of diagnostic criteria for MetSyn, it is a major cardiometabolic abnormality associatedwithMetSyn (11) .IRcontributestothepathogenesisofT2D (11, 12) . Although, there is a lack of consistent criteria in diagnosing MetSyn in children, the National Cholesterol Education ProgramAdult Treatment Panel III (NCEP-ATP III) criteria are the most widely used (13) . In US children, the prevalence of MetSyn has risen from 6.4% in 1999-2000 to 8.6% in 2001-2006 (14, 15) .
Low circulating 25(OH)D has been linked to MetSyn (16, 17) and other cardiometabolic risk factors (3, 12) . It has been reported that vitamin D reduces the risk of T2D by preserving insulin secretion and reducing IR (18, 19) . However, there are inconsistent data that relate vitamin D status with glucose homeostasis (20) (21) (22) (23) . In addition, vitamin D insufficiency has been linked to elevated inflammation (24) . C-reactive protein (CRP) is a predictor of elevated inflammation (25, 26) , which has been linked to an increased risk of CVD (27, 28) , obesity (29) , and MetSyn (30, 31) . Due to the presence of vitamin D receptors (VDRs) on pancreatic b cells (4) and inflammatory cells (32) , there is a potential role for vitamin D in IR and inflammation. No epidemiologic studies based on nationally representative data have investigated the relation between serum 25(OH)D and IR and inflammation in children.
Recently, the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC) updated serum 25(OH)D data files, replacing previous data files for public use in November 2010. The revised adjusted data account for drifts in the serum 25(OH)D assay performance over time. In the data advisory, the NCHS specifically recommended that the adjusted data rather than previously available unadjusted data be used for all analyses of serum 25(OH)D concentrations for NHANES 2000-2006 (33) . Thus, previously reported associations in children using the unadjusted serum 25(OH)D data from NHANES 2001-2002, 2003-2004, and 2005-2006 cycles were likely either over-or underestimated inadvertently (3, 15, 16) . Therefore, in this study, we report the association between serum 25(OH)D and the prevalence of MetSyn, individual components of MetSyn, CRP, and homeostatic model assessment-insulin resistance index (HOMA-IR) in children with the use of the recently updated serum 25(OH)D data from nationally representative sample surveys of the US population.
METHODS

Overview of survey description
The NCHS conducts large, nationally representative sample surveys known as NHANES on the civilian, noninstitutionalized US population by using a stratified, multistage, probability sample survey design. NHANES were conducted as annual surveys beginning in 1999. Data are released in 2-y cycles for public use. Data on demographic characteristics, diet, and health are collected from personal interviews. Physical examinations and collection of blood and urine samples are conducted in the Mobile Examination Center (MEC). Low-income persons, adolescents, persons aged 60 y, non-Hispanic blacks, and Hispanics/Mexicans were oversampled to yield reliable estimates for these groups.
The detailed description of the survey methodologies and analytic guidelines were reported elsewhere (34) Periodically, NHANES data files are updated by the NCHS, which replaces previous data files. One such update occurred in November 2010 for serum 25(OH)D data because of changes in serum 25(OH)D assay over time. At that time, NCHS issued a data advisory for vitamin D recommending that investigators use the assay-adjusted data rather than previously available unadjusted data. A detailed description of this data advisory for serum 25(OH)D is found elsewhere (33) .
Description of metabolic syndrome
MetSyn in children and adolescents was defined according to the modified NCEP-ATP III criteria (13) . According to these criteria, the MetSyn phenotype requires the presence of 3 of the following: 1) waist circumference (WC) 90th percentile for age and sex; 2) triglycerides 110 mg/dL (1.24 mmol/L); 3) HDL cholesterol 40 mg/dL (1.03 mmol/L), 4); either systolic BP (SBP) or diastolic BP (DBP) 90th percentile for age and sex, use of BP medication, or previous diagnosis of BP; and 5) fasting glucose 100 mg/dL (5.55 mmol/L), current diabetes status, or current insulin or hypoglycemic medication use. These criteria (3 out of 5) were applied to generate the cases of MetSyn phenotypes.
Description of the study sample , and 4 individuals were excluded due to missing data for MetSyn phenotype, body mass index (BMI) , and supplement use, respectively. After applying the above exclusion criteria, the sample consisted of 5867 children and adolescents (weighted sample: 27,812,647). This sample was used for the data analysis of measurement of association between prevalence of MetSyn and serum 25(OH)D concentrations.
Sample sizes for the data analysis of measurement of association between various individual cardiometabolic risk factors and serum 25(OH)D concentrations varied. Out of 6873 total eligible persons, after applying the above-mentioned exclusion criteria sequentially (serum 25(OH)D, cardiometabolic risk factors, BMI, and supplement use), 5377 subjects had data for WC, 2599 subjects had data for fasting blood glucose, 5398 subjects had data for serum HDL cholesterol, 2581 had data for serum triglycerides, 5281 had data for SBP, 5313 had data for DBP, and 5470 subjects had data for serum CRP. The sample size for IR measurement was 2573. These subjects had data for both fasting glucose and serum insulin concentrations.
Description of study variables
Potential confounding variables considered in the data analysis were age, sex, race-ethnicity, BMI, poverty-income ratio (PIR), season of survey, use of supplements, smoking, and alcohol intake. Subjects were categorized into 12-15-y and 16-19-y age groups. Race-ethnicity was self-reported as non-Hispanic white, nonHispanic black, Hispanic/Mexican American, and other (persons of multirace and persons with race-ethnicity other than non-Hispanic white, non-Hispanic black, or Mexican/Hispanic). PIR is the ratio of income to the family's appropriate poverty threshold (35) . PIR was categorized as below poverty (,1.0), middle income (1.0-2.5), and higher income (.2.5). Individuals with no data for PIR were placed into the fourth category, ie, "not reported." To avoid damage to the MECs, data in the northern United States were collected in summer (1 May-31 October) and data in the south were collected in winter (1 November-30 April).
Data for WC, BMI, and BP were obtained from the examination component of NHANES. Age-and sex-specific 90th percentiles of WC were derived. Measurement of WC has been described elsewhere in detail (36) . BMI was categorized as normal weight (,85th percentile) and overweight and obese (85th percentile) for age and sex. BP was measured with a mercury sphygmomanometer (36) . Age-and sex-specific 90th percentiles of SBP and DBP measurements were derived. The participants who answered "yes" to the question "Did you take supplements in the past 30 d?" were regarded as supplement users. Smoking status and alcohol intake variables were also considered in the data analysis. However, these variables were not significantly related to either vitamin D or MetSyn in this study sample; therefore, smoking and alcohol variables were dropped from the analysis.
Biochemical measurements
Blood samples were collected by venipuncture in MECs according to standard protocols (37) (38) (39) . Serum 25(OH)D concentrations were determined by using the Diasorin RIA kit assay (Stillwater, MN) at the National Center for Environmental Health, CDC, Atlanta, GA. Serum HDL cholesterol was analyzed by using the heparin manganese precipitation method in The multivariate-adjusted means for WC, fasting glucose, triglycerides, BP, HDL cholesterol, HOMA-IR, and CRP across tertiles of serum 25(OH)D concentrations were generated by using regression analysis after the data were adjusted for sex, age, raceethnicity, supplement use, season of survey, BMI, and PIR. Individual multivariate linear regression models were developed to ascertain the association between serum 25(OH)D and WC, fasting blood glucose, HDL cholesterol, triglyceride, SBP, DBP, CRP, and HOMA-IR. Because the distribution of fasting glucose, triglycerides, CRP, and HOMA-IR were skewed, these variables were log-transformed in the analysis. Multiple comparisons with Bonferroni correction were performed to determine significant differences between the adjusted meansfor serum25(OH)D tertiles for each indicator of MetSyn (P , 0.0167). We also determined interactions between serum 25(OH)D and confounding variables. The interaction terms were included in the model. A P 0.05 was considered significant in all analyses.
RESULTS
The study population consisted of 50.6% boys and 49.4% girls. The mean age of the sample was 15.4 y. Of the 5867 subjects, 62.7% were non-Hispanic white, 14.8% were non-Hispanic black, and 17% were Hispanics/Mexicans. The percentage of subjects in 12-15-y and 16-19-y age groups was similar (51.6% and 48.4%, respectively). Approximately 25% of the study population reported having taken a supplement within 1 mo before the survey. Approximately 58% of the subjects were examined in the summer. The (Figure 1) . The cardiometabolic characteristics of the study population are given in Table 1 .
The proportion of subjects in the lowest 25(OH)D tertile category (,48.1 nmol/L) was significantly higher for females than for males (P , 0.001), for non-Hispanic blacks than for non-Hispanic whites (P , 0.001), for the PIR ,1.0 group than for the PIR 2.5 group (P , 0.001), for those examined in the winter than for those examined in the summer (P , 0.001), for non-supplement users than for supplements users (P , 0.001), and for persons with a BMI 85th percentile than for those with a BMI ,85th percentile (P , 0.001) ( Table 2) .
The association between serum 25(OH)D concentrations and prevalence of MetSyn is presented in Table 3 . The proportion of subjects with MetSyn in the first-tertile serum 25(OH)D group was significantly higher than of those in the third-tertile serum 25 (OH)D group (P , 0.001 for chi-squared statistic). Serum 25(OH) D was significantly associated with prevalence of MetSyn in unadjusted (P , 0.005 for trend) and multivariate-adjusted (P , 0.04 for trend) logistic regression analysis. In the multivariateadjusted analysis, the likelihood of children having MetSyn in the lowest serum 25(OH)D tertile category was 1.71 (95% CI: 1.11, 2.65; P , 0.01) compared with subjects in the highest serum 25(OH)D tertile category. Table 4 . An inverse association between serum 25(OH)D and WC (P for linear trend ,0.001), SBP (P for linear trend = 0.01), and HOMA-IR score (P for linear trend = 0.002) and a positive association between serum 25(OH)D and HDL cholesterol (P for linear trend ,0.001) were found in the multivariate-adjusted regression analysis. WC, SBP, and HOMA-IR were significantly higher and HDL cholesterol was significantly lower in the lowest serum 25(OH)D tertile group than in the highest serum 25(OH)D tertile group (P , 0.0167). There was no association between serum 25(OH)D and fasting plasma glucose (P = 0.81), serum triglycerides (P = 0.94), DBP (P = 0.51), and CRP (P = 0.18). Additional analysis showed no association between serum 25(OH)D and CRP in children with a BMI 85th percentile (P = 0.18; data not shown). 2 Significance determined by Rao-Scott chi-square test. 3 Ratio of income to the family's appropriate poverty threshold, provided by the US Census Bureau. A ratio of ,1.0 is considered to be the belowpoverty threshold. 4 Data collected during 1 May-31 October (summer) and 1 November-30 April (winter). 5 Participants who took supplements 1 mo before the survey was conducted.
The association between serum 25(OH)D concentrations and various cardiometabolic risk factors is presented in
risk factors in children in a nationally representative sample survey using the assay-adjusted serum 25(OH)D data. In this study, we report that serum 25(OH)D was inversely related to prevalence of MetS phenotype, WC, SBP, and HOMA-IR. Serum 25(OH)D was also directly related to HDL cholesterol regardless of obesity.
No relation was found between serum 25(OH)D and CRP. To our knowledge, this is the first study to investigate the association between serum 25(OH)D and IR as assessed by HOMA in a nationally representative sample of children. In this large population-based study, we found that children in the lowest serum 25(OH)D tertile had significantly higher HOMA-IR scores than did those in the highest 25(OH)D tertile. A few cross-sectional studies in adults (12, 19, 21) and a small cohort study on children (45) have reported an association between serum 25(OH)D and IR. In contrast, vitamin D intervention studies have yielded inconsistent results on lowering IR (46) . This is likely due to differences in dosage and duration of vitamin D. Similar to our findings, a small cross-sectional study in 85 children recently found that serum 25(OH)D was inversely associated with HOMA-IR (45) . Previous studies in adults have suggested an inverse association between serum 25(OH)D and IR and a direct association between 25(OH)D and insulin sensitivity (12, 19, 21) . In contrast, others (47) found no association between serum 25(OH)D and IR in obese children. The lack of association may be due to a small sample size or a limited range of serum 25(OH)D with more than one-quarter of the subjects with severe vitamin D deficiency [25(OH) 2 
The mechanism by which vitamin D reduces IR includes its effects on enhancing insulin sensitivity by up-regulating the insulin receptors and activating peroxisome proliferator-activated receptor-c expression, a transcription factor important for fatty acid metabolism in adipose and muscle tissues (48) . Also, in response to 1,25-dihydroxyvitamin D [1,25(OH) 2 D], calbindin is synthesized, which alters insulin action on the adipocyte and affects the secretion of insulin from pancreatic b cells (12, 18) . The association between vitamin D and IR is further supported by the presence of polymorphisms in the VDR gene. These polymorphisms (Apa I, BSM I, Taq I, and Fok I) have been found to modify insulin secretion leading to IR and dysregulation of glucose homeostasis (49, 50) . Although the evidence for vitamin D supplementation is building, randomized controlled studies are needed before vitamin D supplementation can be considered as a potential intervention strategy for the management of IR and T2D.
With the use of previously available unadjusted data from We found that serum 25(OH)D was inversely associated with WC, which correlates with a previously reported inverse association between serum 25(OH)D and obesity (51) . Although the exact reasons for low serum 25(OH)D in obese individuals are not clear, it has been shown that there was no difference in endogenous synthesis of vitamin D in the dermis between obese and nonobese persons when exposed to sunlight; however, the release of vitamin D from the dermis into the circulation is reduced in obese persons, leading to depressed circulating 25(OH)D (52) . Sequestering of vitamin D within the adipose tissue might also explain low circulating 25(OH)D in obesity (52) . In addition, overweight and obese children generally spend less time outdoors due to sedentary (13) . The presence of 3 of the following criteria are required: waist circumference .90th percentile for age and sex; triglycerides .110 mg/dL (1.24 mmol/L); HDL cholesterol ,40 mg/dL (1.03 mmol/L); either systolic or diastolic blood pressure .90th percentile for age, sex, and height or use of blood pressure medication; and fasting glucose .100 mg/dL (5.55 mmol/L), current diagnosis of diabetes, or current use of insulin or oral hypoglycemic drugs.
2 Significance determined by Rao-Scott chi-square test. 3 Significantly different from the referent category, tertile 3. 4 Referent category. 5 Significant for the effect of metabolic syndrome prevalence in the unadjusted logistic regression analysis. 6 Significant for the effect of metabolic syndrome prevalence in the multivariate-adjusted logistic regression analysis. The analysis was adjusted for sex, age, race-ethnicity, and BMI. Interaction between race-ethnicity and BMI was significant (P = 0.023). Age, poverty-income ratio, season of survey, and use of supplements were not significant in this model. lifestyles, which lead to less exposure to ultraviolet B radiation (53) . These are possible explanations for depressed endogenous vitamin D synthesis and circulating 25(OH)D in obesity.
Similar to our findings using unadjusted vitamin D data from NHANES III, Judd et al (8) found that serum 25(OH)D (,50 nmol/L) was inversely associated with SBP in adults. Also, in the prospective cohort of the first Nurses' Health Study, it was shown that plasma 25(OH)D was inversely related to the incidence of hypertension (54) . Vitamin D is known to play a role in the regulation of BP (55) . The renin-angiotensin-aldosterone system (RAS) regulates BP, electrolyte, and blood volume homeostasis (56) . In obese persons with hypovitaminosis D, the perturbation in RAS may be the cause of elevated BP (57) . The RAS is up-regulated in obesity, and excessive RAS stimulation leads to elevated BP (58) . A possible explanation for the association between vitamin D and BP in obesity may be because vitamin D is stored in adipose tissue where all components of the RAS are also synthesized (59) . The role of vitamin D in regulating RAS is further supported by the fact that the VDR knockout mice experienced elevated renin and BP (60) . On the basis of the evidence, vitamin D supplementation for lowering BP has been proposed (8) .
Because VDRs are located on immune cells that synthesize and secrete 1,25(OH) 2 D, it is believed that vitamin D plays a role in inflammation (61) . The underlying mechanism behind the inverse relation between vitamin D and the inflammatory marker CRP is not clear. It has been found that the expression of cytokines is down-regulated by 1,25(OH) 2 D via VDR signaling through the regulation of nuclear transcription factor jB (32). However, in the Framingham study, Shea et al (62) found no association of 25(OH) D with inflammation, which was similar to our findings. The lack of a relation with CRP is likely due to fewer overweight and obese children in this study.
The use of national surveys with a large sample size of children allowed us to examine the relation of serum 25(OH)D with various cardiometabolic risk factors after taking several confounding variables into account. The confirmation of a cause-andeffect relation is not possible due to the cross-sectional design of the study. In conclusion, the assay-adjusted NHANES 2001-2006 vitamin D data show that children with poor vitamin D status are at increased risk of several cardiometabolic risk factors regardless of obesity. The relation between low vitamin D status and MetSyn and IR is a concern because children with MetSyn are at high risk of future CVD and T2D. Because of negative health outcomes associated with MetSyn and poor vitamin D status, an examination of vitamin D supplementation in reversing components of MetSyn and ultimately in the prevention of CVD appears to be warranted.
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